Presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, the trial revealed that eltrombopag ...

When a room of physicians at ASH 2024 was asked whether they had prescribed a gene therapy in a commercial context, only a handful said yes.

Anita D'Souza, MD, discusses an abstract looking at the combination of teclistamab-cqyv, daratumumab, and pomalidomide in 2 ...

The FDA issued a second, expanded recall of duloxetine after higher than acceptable levels of a cancer-causing chemical were ...

No bleeding episodes were seen over three years for 64% of hemophilia A patients given giroctocogene fitelparvovec in a trial ...

Editas, which was unable to identify a development or licensing partner for reni-cel, is focusing its resources on its in vivo pipeline.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Two researchers from Huntsman Cancer Institute at the University of Utah (the U) have discovered a gene variant found in high ...

Hematology patients, Gong explains, can have mutations that affect just one or a few base pairs—small insertions or deletions ...

Lead researcher Timothy S. Fenske, M.D., a professor of medicine at the Medical College of Wisconsin, presented the results ...

Researchers at Penn Medicine's Abramson Cancer Centre and the University of Pennsylvania's Perelman School of Medicine have ...